Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H McCabe

Showing results (151-160 of 259) with videos related to

Pageof 26
Sort By:
Journal of the Neurological Sciences|December 16, 2014
Relationship between ADAMTS13 activity, von Willebrand factor antigen levels and platelet function in the early and late phases after TIA or ischaemic strokeDominick J H McCabe, Stephen J X Murphy, Richard Starke, et al.
British Journal of Haematology|January 13, 2011
Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: first results from the TRinity AntiPlatelet responsiveness (TrAP) studyWilliam Oliver Tobin, Justin A Kinsella, Daniel Ronan Collins, et al.
Circulation|February 13, 2003
Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromesJames A de Lemos, David A Morrow, Marc S Sabatine, et al.
Neurology|March 26, 2003
Occurrence of seizure clusters and status epilepticus during inpatient video-EEG monitoringA B Rose, P H McCabe, F G Gilliam, et al.
Journal of Thrombosis and Thrombolysis|June 7, 2008
A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trialDavid A Morrow, Chaim M Brickman, Sabina A Murphy, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|May 12, 2006
Association of a history of systemic hypertension with mortality, thrombotic, and bleeding complications following non-ST-segment elevation acute coronary syndromeRaphaelle Dumaine, C Michael Gibson, Sabina A Murphy, et al.
Journal of the American College of Cardiology|March 1, 1995
Angiographic predictors of reocclusion after thrombolysis: results from the Thrombolysis in Myocardial Infarction (TIMI) 4 trialC M Gibson, C P Cannon, R N Piana, et al.
Circulation|April 20, 1999
Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study GroupC M Gibson, S A Murphy, M J Rizzo, et al.
American Heart Journal|November 8, 2002
Minimal ST-segment deviation: a simple, noninvasive method for identifying patients with a patent infarction-related artery after fibrinolytic administrationHoward A Cooper, James A de Lemos, David A Morrow, et al.
The Journal of Physical Chemistry. A|June 26, 2009
12C/13C ratio in ethane on titan and implications for methane's replenishmentDonald E Jennings, Paul N Romani, Gordon L Bjoraker, et al.
Pageof 26

Showing results (151-160 of 259) with videos related to

Sort By:
Pageof 26
Journal of the Neurological Sciences|December 16, 2014
Relationship between ADAMTS13 activity, von Willebrand factor antigen levels and platelet function in the early and late phases after TIA or ischaemic strokeDominick J H McCabe, Stephen J X Murphy, Richard Starke, et al.
British Journal of Haematology|January 13, 2011
Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: first results from the TRinity AntiPlatelet responsiveness (TrAP) studyWilliam Oliver Tobin, Justin A Kinsella, Daniel Ronan Collins, et al.
Circulation|February 13, 2003
Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromesJames A de Lemos, David A Morrow, Marc S Sabatine, et al.
Neurology|March 26, 2003
Occurrence of seizure clusters and status epilepticus during inpatient video-EEG monitoringA B Rose, P H McCabe, F G Gilliam, et al.
Journal of Thrombosis and Thrombolysis|June 7, 2008
A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trialDavid A Morrow, Chaim M Brickman, Sabina A Murphy, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|May 12, 2006
Association of a history of systemic hypertension with mortality, thrombotic, and bleeding complications following non-ST-segment elevation acute coronary syndromeRaphaelle Dumaine, C Michael Gibson, Sabina A Murphy, et al.
Journal of the American College of Cardiology|March 1, 1995
Angiographic predictors of reocclusion after thrombolysis: results from the Thrombolysis in Myocardial Infarction (TIMI) 4 trialC M Gibson, C P Cannon, R N Piana, et al.
Circulation|April 20, 1999
Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study GroupC M Gibson, S A Murphy, M J Rizzo, et al.
American Heart Journal|November 8, 2002
Minimal ST-segment deviation: a simple, noninvasive method for identifying patients with a patent infarction-related artery after fibrinolytic administrationHoward A Cooper, James A de Lemos, David A Morrow, et al.
The Journal of Physical Chemistry. A|June 26, 2009
12C/13C ratio in ethane on titan and implications for methane's replenishmentDonald E Jennings, Paul N Romani, Gordon L Bjoraker, et al.
Pageof 26